TrialLeukemia2022

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.

Nikolaus Jahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.